Olzhas Bektenov Discusses Development of Investment Cooperation in Healthcare with International Business

Prime Minister of the Republic of Kazakhstan Olzhas Bektenov chaired a meeting of the Council on Improving the Investment Climate, which reviewed issues of attracting investment and introducing innovations in the healthcare sector. Discussions focused on expanding pharmaceutical production, increasing the accessibility of modern treatment methods, and improving conditions for investors.

The Prime Minister emphasized that protecting the health of the nation has been enshrined in the Constitution of Kazakhstan for the first time.

“In his recent Address to the People of Kazakhstan, the Head of State also set the task of accelerated construction of medical facilities with the involvement of private capital. To achieve these goals, the Government is implementing the Concept for the Development of Healthcare until 2029 and the Concept for the Development of Healthcare Infrastructure for 2024–2030. These strategic documents provide for improving medical care, introducing innovative technologies, and strengthening medicine supply,” Olzhas Bektenov noted.

The measures being taken are yielding positive results. Life expectancy has approached 76 years, and thanks to the "Modernization of Rural Healthcare" project, medical services have become accessible to approximately 1 million citizens. Over three years, more than 800 healthcare facilities have been built in the regions, with another 70 planned. Projects for multidisciplinary, university, and children's hospitals are being implemented with the participation of foreign investors and international financial institutions (IFIs).

Attention is also being paid to the development of the pharmaceutical industry. By the end of last year, the market volume exceeded 1.2 trillion tenge, growing by 31%. Eight major investment projects worth over 390 billion tenge are under development, aimed at producing around 500 types of medicines and creating new jobs. In April, Kazakhstan became the first among the CIS countries to reach Maturity Level 3 of its national regulatory system under the WHO methodology and introduced the "single window" principle. An accelerated 15-working-day registration procedure for medicines from countries with high regulatory standards has also been introduced.

Proposals from the international business community were voiced by Jeff Erlich, Executive Director of the American Chamber of Commerce in Kazakhstan (AmCham); Julie Stufft, U.S. Ambassador to Kazakhstan; Adilet Nazarbayev, General Director of Johnson & Johnson Kazakhstan LLP; Yelena Trogova, General Director of AstraZeneca Kazakhstan; and Dmitry Kozenkov, Regional Director of Pfizer for Kazakhstan, Central Asia, the Caucasus, and Mongolia, and Member of the AmCham Board of Directors.

U.S. Ambassador to Kazakhstan Julie Stufft emphasized the importance of a stable and predictable investment climate in healthcare and pharmaceuticals. Issues of improving the accessibility of medicine supply were also touched upon.

General Director of Johnson & Johnson Kazakhstan Adilet Nazarbayev raised issues of improving mechanisms for including medicines in the state reimbursement list and gradually increasing healthcare financing. The importance of patient access to modern drugs and ensuring sustainable financing of the healthcare system, taking into account the growing needs of the population, was noted.

General Director of AstraZeneca Kazakhstan Yelena Trogova addressed the provision of essential medicines to patients with rare diseases. Attention was paid to improving approaches to forming the list of such drugs to ensure continuity of therapy.

Regional Director of Pfizer for Kazakhstan, Central Asia, the Caucasus, and Mongolia Dmitry Kozenkov outlined priority areas for the development of the pharmaceutical industry. In particular, emphasis was placed on further work on localizing production, protecting intellectual property, and developing a predictable regulatory environment.

Deputy Prime Minister – Minister of National Economy Serik Zhumangarin and Minister of Healthcare Akmaral Alnazarova commented on the issues raised.

Following the meeting, Olzhas Bektenov instructed relevant state bodies to thoroughly review the proposals of international pharmaceutical companies and work out measures to further improve the investment climate in the industry. Special attention was paid to attracting investment, localizing medicine production, introducing advanced technologies, and increasing the accessibility of quality medical care for the population.

#Olzhas Bektenov #The Prime Minister of the Republic of Kazakhstan #Healthcare #President's instruction

Stay updated about the events of the Prime minister and the Government of Kazakhstan - subscribe to the official Telegram channel

Subscribe